Clinical impact of a new automated system employed for peripheral blood stem cell collection

Journal of Clinical Apheresis

Volumn 21, Issue 4, 2006, Pages 227-232

  Del Fante, Claudia ^a   Perotti, Cesare ^a   Viarengo, Gianluca ^a   Bellotti, Laura ^a   Parisi, Cristina ^a   Marchesi, Andrea ^a   Tinelli, Carmine ^a   Salvaneschi, Laura ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Automated collection; Leukapheresis; Stem cell transplant

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACCURACY; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOMATION; BREAST CANCER; CD34 SELECTION; CELL SEPARATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRODUCT RECOVERY; SCHOOL CHILD; STANDARDIZATION; WORKLOAD;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ANTIGENS, CD34; AUTOMATION; BLOOD CELL COUNT; BLOOD DONORS; BREAST NEOPLASMS; CHILD; COLONY-FORMING UNITS ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 33845948005     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20102     Document Type: Article

References (27)

1. Sohn SK, Kim JG, Kim DH, Baek JH, Lee KB. Diverse clinical applications using advantages of allogeneic peripheral blood stem cell transplantation. Int J Hematol 2004;79:457-461.
2. Nademanee A, O'Donnell MR, Snyder DS. Schmidt GM, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood 1995;85:1381-1390.
3. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005;23:5074-5087.
4. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant 2005;36:575-590.
5. Panse JP, Heinifeld S, Guthrie KA, Maris MB, Maloney DG, Baril BB, Little MT, Chauncey TR, Storer BE, Storb R, Sandmaier BM. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-mycloablative conditioning. Br J Haematol 2005;128:659-667.
6. Ford CD, Lehman C, Strupp A, Kelley L. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 Plus. J Clin Apheresis 2002;17:17-20.
7. Adorno G, Del Proposto G, Palombi F, Bruno A, Ballatore G, Postorino M, Tendas A, Del Poeta G, Isacchi G, Amadori S. Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators. Transfus Apher Sci 2004;30:131-136.
8. Ravagnani F, Siena S, De Reys S, Di Nicola M, Notti P, Giardini R, Bregni M, Mattcucci P, Gianni AM, Pellegris G. Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system. Transfusion 1999;39:48-55.
9. Heuft HG, Dubiel M, Kingreen D, Oertel J, De Reys S, Rick O, Sserke S, Schwella N. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation. Vox Sang 2000;79:94-99.
10. Rowley SD, Prather K, Bui KT, Appel M, Felt T, Bensinger WI. Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion 1999;39:1200-1206.
11. Torrabadella M, Olive T, Ortega JJ, Massuet L. Enhanced HPC recruitment in children using LVL and a new automated apheresis system. Transfusion 2000;40:404-410.
12. Green RH, Watson D. Buchnan S, Morrison AE. A prospective randomised concurrent comparison of the COBE Spectra Version
13. COBE Spectra Version 6 (auto PBSC) and Haemonetics MCS+ cell separators for leukapheresis in patients with haematological and non-haematological malignancies. Transfus Apher Sci 2001;24:85-90.
14. Gidron A, Verma A, Doyle M, Boggio L, Evens A, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J. Can the stem cell mobilization technique influence CD34 cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Bone Marrow Transplant 2005;35:243-246.
15. Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, Cohen K, Duffy B, Groenewegen I, Wiley J, Law P, Hardwick A, Oldham F, Gee A. Highly purified CD34+ positive cells reconstitute hematopoiesis. J Clin Oncol 1996;14:2224-2233.
16. Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo G, D'Hautcourt JL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry (Comm Clin Cytometry) 2000;42:327-346.
17. pos cells. J Biol Regul Homeost Agents 2003;17:247-255.
18. Metcalf D. Technique for the clonal culture of hemopoietic cells: techniques and applications. New York: Elsevier. 1984.
19. Brown RA, Adkins D, Goodnough LT, Haugh JS, Todd G, Wehde M, Hendricks D, Ehlenbeck C, Laub L, DiPersio J. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 1997;15:3067-3074.
20. Morris C, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A, Zangari M, Anaissie E, Tricot G. Mobilization of CD34+ cells in elderly patients with multiple myeloma: influence of age, prior therapy, platelet count, and mobilization regimen. Br J Haematol 2003;120:413-420.
21. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999;39:555-560.
22. Poncliio L, Eaves C, Hogge D, Perotti C, Torretta L, Cerani P, Salvaneschi L, Ascari E, Cazzola M. Both cycling and non-cycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF. Br J Haematol 1997;99:394-402.
23. Tinmouth AT, Freedman J. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature. Transfus Med Rev 2003;17:181-193 (review).
24. Navarro JT, Hernandez JA, Ribera JM, Sancho JM, Oriol A, Pujol M, Milla F, Feliu E. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica 1998;83:998-1000.
25. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18:4705-4708.
26. Ford C, Chan K, Reilly W, Peterson F. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003;43:622-625.
27. Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens I, van Camp B, De Waele M. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells than can be predicted by apheresis. Bone Marrow Transplant 1996;17:509-515.